Total:15
-
2022-03-01 18:07
“Noora” vaccine receives emergency use license
TEHRAN – Noora coronavirus vaccine, developed and produced by Baqiyatallah University of Medical Sciences, affiliated with the Islamic Revolution Guards Corps (IRGC), has received an emergency use license.
-
2021-12-31 17:04
Negotiations underway to export Razi Cov Pars vaccine
TEHRAN – A number of countries have requested to purchase the Iranian-made Cov Pars vaccine for COVID-19, and negotiations are underway to take the necessary measures for export, vice president for research and technology of Razi Vaccine and Serum Research Institute, said.
-
2021-11-17 17:50
By Faranak Bakhtiari
Over 100m doses of COVID-19 vaccine injected
TEHRAN – The number of COVID-19 vaccines injected in the country has exceeded 100 million doses, despite all barriers and difficulties caused by sanctions.
-
2021-11-14 19:00
Cov Pars causes 9-12 months immunity to COVID-19
TEHRAN – Studies show that Cov Pars vaccine, developed by the Razi Vaccine and Serum Research Institute of Iran, makes immunity for 9-12 months against the coronavirus, Reza Bani-Hashemi, the director for research and development at the institute, said on Sunday.
-
2021-11-12 17:12
COVIRAN vaccine to begin clinical trial on children aged 12-18
TEHRAN – COVIRAN BAREKAT vaccine received a license to start a clinical trial on children aged 12 to 18 by the next week, Minoo Mohraz, a member of the National Scientific Committee of COVID-19, has said.
-
2021-11-07 17:39
Monthly COVID-19 vaccine output reaches 10m doses
TEHRAN – The domestic manufacturers of coronavirus vaccine have managed to increase their monthly production to 10 million doses, Seyed Heydar Mohammadi, an official with the Food and Drug Administration, has said.
-
2021-10-08 17:22
Spikogen vaccine licensed for emergency use
TEHRAN – The Food and Drug Administration has issued an emergency permit for the Iranian-Australian Spikogen vaccine, IRNA reported on Thursday.
-
2021-09-13 17:16
Fakhra vaccine enters third phase of human test
TEHRAN – The third phase of the Fakhra vaccine’s human trial started on Monday by being administrated to 40,000 volunteers, IRIB reported.
-
2021-09-08 18:16
Pastu Covac vaccine approved for children under 18
TEHRAN – Pastu Covac, developed jointly by the Pasteur Institute of Iran and Cuba's Finlay Vaccine Institute, is the only homegrown vaccine that includes use in children aged under 18.
-
2021-09-05 18:17
Cov Pars begins third phase of clinical studies
TEHRAN – “Razi Cov Pars” vaccine entered on Sunday the third phase of the human trial, being administrated to 40,000 people, IRIB reported.
-
2021-08-14 20:20
IRCS denies sending coronavirus vaccines to Venezuela
TEHRAN – The Iranian Red Crescent Society (IRCS), has denied sending any shipment of COVID-19 vaccines from Iran to Venezuela.
-
2021-08-01 17:06
More 200,000 doses of COVIRAN vaccine delivered
TEHRAN – Some 200,000 doses of COVIRAN BAREKAT vaccine have been recently delivered to the Ministry of Health for public vaccination, Hassan Jalili, the vaccine’s production manager, said on Sunday.
-
2021-07-31 17:12
“Noora” vaccine successfully passing first phase of clinical trial
TEHRAN – “Noora" coronavirus vaccine, domestically made by Baqiyatallah University of Medical Sciences affiliated to the Islamic Revolution Guard Corps (IRGC), is successfully passing the first phase of the clinical trial.
-
2021-07-26 20:00
Cov Pars to produce 1m doses of vaccine monthly
TEHRAN – One million doses of “Razi Cov Pars” vaccine will be produced each month as of the sixth calendar month Shahrivar (starting August 23), Mohammad-Hassan Fallah Mehrabadi, deputy head of the Razi Vaccine and Serum Research Institute has announced.
-
2021-07-25 16:05
Pastu Covac is world’s only vaccine targeting several mutations: expert
TEHRAN – Pastu Covac coronavirus vaccine, developed jointly by the Pasteur Institute of Iran and Cuba's Finlay Vaccine Institute, is the only vaccine in the world that can fight several mutations simultaneously, Alireza Biglari, head of the Pasteur Institute, has said.